Dr. Alaina Justine Kessler

Negligence, Misleading Results, and System-Driven Decisions at the Expense of Patient Safety I write this review not to discredit the medical profession, but to inform, protect, and drive change. I have deep respect for doctors who dedicate their lives to healing others. Medicine is a noble, life-saving field that requires constant learning, humility, and accountability. But when protocols replace personalized care, and outcomes appear driven by systemic pressures rather than patient safety, we must speak up. Dr. Alaina Kessler oversaw my loved one’s oncology care during her treatment for Stage 0 HER2+ breast cancer at Mount Sinai. What unfolded under her care was a tragic example of what can happen when aggressive, generalized treatment plans are applied to medically complex patients without proper coordination, flexibility, or clinical oversight. *Misleading Assessments and Pre-Surgery Treatment Dr. Kessler recommended pre-surgical chemotherapy, stating that it was effective based… on superficial observations and imaging. However, a post-treatment biopsy showed there had been no meaningful response. In our experience, this led to a false sense of progress and delayed more appropriate interventions. That misstep prolonged suffering and impacted treatment direction. *Aggressive, Non-Individualized Post-Surgery Plan Following surgery, Dr. Kessler prescribed a highly aggressive combination of ado-trastuzumab emtansine and radiation therapy, despite knowing the patient’s fragile health and chronic lung disease. The consequences were immediate and devastating. On the very first day of receiving ado-trastuzumab emtansine, my loved one developed a painful, burning rash across her body—an adverse reaction that, to our surprise, was not acknowledged or addressed. She soon began coughing up blood, and her condition deteriorated rapidly, including extreme fatigue, nausea, and respiratory distress. Her lung health worsened, leading to hospitalization and, ultimately, her passing. *Systemic Protocols Over Personalized Care Rather than pacing treatments to allow for monitoring and recovery, Dr. Kessler continued with concurrent therapies—decisions that, from our perspective, reflected hospital protocols or institutional pressure rather than customized care. There seemed to be little effort to coordinate with specialists familiar with her preexisting pulmonary and autoimmune conditions. Despite escalating symptoms, the treatment course remained unchanged. *A Kind Person, But Lacked Clinical Judgment Dr. Kessler was personable and not rushed during visits. She was kind and professional in demeanor. However, her explanations often centered around the idea that “the benefits outweigh the risks,” even as serious complications arose. In my experience, her recommendations seemed to follow standardized protocols rather than being thoughtfully adapted to my loved one’s unique risks. Her treatment felt impersonal, like a checkbox exercise, rather than a collaborative, evidence-based plan. *Call for Reflection and Change Oncology care must be collaborative, cautious, and guided by both evidence and deep listening—not just pathology reports. In this case, the absence of coordination, the reliance on broad treatment plans, and the failure to respond to warning signs resulted in irreversible harm. Suggestions for Improvement: *Rely on objective data, not just surface-level assessments. *Tailor treatments to the patient’s full medical history, especially in complex cases. *Collaborate with other specialists to ensure comprehensive care. *Question institutional routines when they conflict with individualized safety. *Reassess and adjust treatment when the patient’s body is clearly not tolerating it. My hope in sharing this experience is to empower other families to ask tough questions, seek second opinions, and advocate fiercely for truly individualized care. Every patient deserves not just kindness, but competent, careful, and coordinated tre